Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share (the "Shares")
-
Shares outstanding
-
274M
-
Number of holders
-
360
-
Total 13F shares, excl. options
-
252M
-
Shares change
-
+7.41M
-
Total reported value, excl. options
-
$5.99B
-
Value change
-
+$238M
-
Put/Call ratio
-
0.91
-
Number of buys
-
196
-
Number of sells
-
-145
-
Price
-
$23.74
Significant Holders of EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") (EXEL) as of Q2 2020
421 filings reported holding EXEL - EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") as of Q2 2020.
EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") (EXEL) has 360 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 252M shares
of 274M outstanding shares and own 92.08% of the company stock.
Largest 10 shareholders include BlackRock Inc. (31.5M shares), VANGUARD GROUP INC (28.8M shares), RENAISSANCE TECHNOLOGIES LLC (23M shares), PRICE T ROWE ASSOCIATES INC /MD/ (13.5M shares), Meditor Group Ltd (12.8M shares), FARALLON CAPITAL MANAGEMENT LLC (10.3M shares), JPMORGAN CHASE & CO (9.7M shares), STATE STREET CORP (9.67M shares), PICTET ASSET MANAGEMENT LTD (6.39M shares), and JANUS HENDERSON GROUP PLC (5.3M shares).
This table shows the top 360 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.